BANGALORE, India | 11th August 2020: Next-generation sequencing (NGS) is an innovative technique for low-cost, high-speed sequencing of genomes with increased efficacy. NGS is used in various applications such as exploration of biomarkers, oncology trials, precision medicine, agriculture & animal testing, and so on.
The global next generation sequencing market size was valued at USD 4,533 Million in 2018 and is estimated to reach USD 18,565 Million by 2026, growing at a CAGR of 19.2% from 2019 to 2026.
This research offers a comprehensive overview of the latest industry dynamics for next-generation sequencing and demand prediction projections from 2019 to 2026, which defines the business prospects that prevail.
TRENDS INFLUENCING THE NEXT GENERATION SEQUENCING MARKET SIZE
NGS has simplified the study of nucleotides and has effectively replaced traditional genomics methods. This factor is expected to increase the next generation sequencing market size. Moreover, the emergence of genome mapping systems is also expected to fuel the global market’s growth for next-generation sequencing.
One of the key developments boosting the demand is the miniaturization of third-generation devices with the launch of palm-sized sequencers. The continued advancement of next-generation sequencing technology’s performance and the cost is projected to fuel the growth of non-conventional applications such as Agri-genomics and infectious disease research.
Next generation sequencing provides a comprehensive description of the molecular structure of a tumor that helps further accelerate the therapy prescription protocols. In addition, the introduction of preventive cancer screening services provides considerable growth opportunities for next generation sequencing market size.
NEXT GENERATION SEQUENCING MARKET SHARE ANALYSIS
Based on the application, in 2018, the diagnostics segment held the largest Next generation sequencing market share. This significant market share can be attributed to factors such as the number of new cancer cases across the globe, a favorable reimbursement scenario for NGS-based testing in the US, and a growing focus of key market players on developing NGS-based cancer products & services.
Based on end-users, the academic institutes & research centers held the largest Next generation sequencing market share in 2018. This is due to the growing number of partnerships between Next generation sequencing market leaders and academic & research institutions, a favorable funding scenario for region-wide genomics research, and the creation of cost-effective NGS products and testing services.
Based on the region, North America is expected to hold the largest market share during the forecast period. The dominance of North America is due to factors such as the growing use of NGS in diagnostics and genomics science, the availability of research funding, and the development of approaches for NGS data analyses.
The Asia Pacific market is expected to witness the highest growth rate during the projected period. The rapid growth can be attributed to the initiatives taken by Asian companies as well as government bodies that aim to improve their genomics industry and generate revenue.
Inquire For Regional Reports: https://reports.valuates.com/request/regional/ALLI-Auto-4C357/Next_Generation_Sequencing_NGS_Market
TOP COMPANIES IN THE NEXT GENERATION SEQUENCING MARKET
The next generation sequencing market is highly competitive, with few players dominating the market. Agreements and partnerships between various industry leaders and health centers are being used as a market strategy to get a strong foothold in the market.
The top companies in the next-generation sequencing are, Illumina, Inc., Thermo Fisher Scientific, Inc., Pacific Biosciences of California, Inc., Beijing Genomics Institute, Qiagen N.V., 454 Life Sciences Corporation (Roche Holding AG), Agilent Technologies, Inc., Perkinelmer, Inc., Genomatix GmbH, and PierianDx. Other prominent players in the value chain include Eurofins Scientific, Gatc Biotech AG, Macrogen, Inc., Oxford Nanopore Technologies, Ltd., Bio-Rad Laboratories, Inc., DNASTAR, Inc., Biomatters Ltd., Partek Inc., New England Biolabs, Inc. and Myriad Genetics, Inc.
These organizations are partnering with clinical research agencies to decode the pathogenesis of specific diseases using next-generation sequencing platforms.
NEXT GENERATION SEQUENCING MARKET ON THE BASIS OF PRODUCT
- Sample Preparation Consumables
- DNA Fragmentation, End Repair, A-Tailing, and Size Selection
- Library Preparation & Target Enrichment
- Quality Control
- Other Consumables.
- Sample Preparation Consumables
- Ion Torrent
- Pacbio Rs II and Sequel System
- Other Sequencing Platforms.
- Sequencing Services
- RNA Sequencing
- Whole Exome Sequencing
- Whole Genome Sequencing
- Targeted Sequencing
- Chip Sequencing
- De Novo Sequencing
- Methyl Sequencing.
- Data Management Services
- NGS Data Analysis Services
- NGS Data Analysis Software & Workbenches
- ment and Cloud Computing SolutionsNGS Storage, Manage.
- Sequencing Services
NEXT GENERATION SEQUENCING MARKET ON THE BASIS OF BY APPLICATION
- Biomarkers and Cancer
- Reproductive Health
- Personalized Medicine
- Agriculture and Animal Research
- Other Applications.
NEXT GENERATION SEQUENCING MARKET ON THE BASIS OF TECHNOLOGY
- Sequencing by Synthesis
- Ion Semiconductor Sequencing
- Sequencing by Ligation
- Single-Molecule Real-Time Sequencing
- Other Technologies.
NEXT GENERATION SEQUENCING MARKET ON THE BASIS OF END USER
- Academic and Clinical Research Centers
- Pharmaceutical and Biotechnology Companies
- Hospitals and Clinics
- Other End User.
KEY PLAYERS PROFILED
- Illumina, Inc.
- Thermo Fisher Scientific, Inc.
- Pacific Biosciences of California, Inc.
- Beijing Genomics Institute
- Qiagen N.V.
- 454 Life Sciences Corporation (Roche Holding AG)
- Agilent Technologies, Inc.
- Perkinelmer, Inc.
- Genomatix GmbH
Buy Now for Single User: https://reports.valuates.com/api/directpaytoken?rcode=ALLI-Auto-4C357&lic=single-user
Buy Now for Enterprise Licence: https://reports.valuates.com/api/directpaytoken?rcode=ALLI-Auto-4C357&lic=enterprise-user
- Next-generation Sequencing Informatics Market Report
Major factors driving the growth of Next-generation Sequencing Informatics Market size include lower sequencing costs with the use of NGS informatics, government policies to encourage the use of NGS, improved speed & versatility provided by NGS, and constant technological advancement and innovations.
The top companies in the Next-generation Sequencing Informatics Market are Burhani Guards International, GENEWIZ, GATC Biotech AG, Biomatters Ltd., DNASTAR, Genomatix GmbH, Qiagen N.V., Illumina Inc., Thermo Fisher Scientific Inc., and Partek Incorporated.
- Metagenomics Next Generation Sequencing Market Report
Metagenomics Next Generation Sequencing Market development is primarily influenced by factors such as the substantial use of metagenomics in various fields, the numerous interventions and financing of large-scale sequencing projects by government & private bodies, and the declining cost of sequencing.
- Clinical Oncology Next Generation Sequencing (NGS) Market Report
The key factor contributing to the growth of Clinical Oncology Next Generation Sequencing (NGS) Market size is the improved understanding of the genetic markers of virulence and resistance.
- Library Preparation and Target Enrichment for Next Generation Sequencing Product Market Report
- Next Generation Sequencing (NGS) Data Analysis Market Report
North America is home to many well-established NGS data analytics organizations. A large number of NGS research initiatives are being undertaken in Canadian universities, which in turn has resulted in a tremendous demand for NGS data processing, impacting the growth of revenues in the region. North America is expected to continue to be the fastest-expanding and biggest NGS data analysis market during the project period.
- Dna Next Generation Sequencing Market Report
- Next Generation Sequencing (NGS) Software Market Report